Key result
Pre-pregnancy obesity linked to ~38% higher odds of peripartum cardiomyopathy.
Why the study?
The study was conducted to evaluate the contribution of pre-pregnancy obesity and overweight to peripartum cardiomyopathy.
Does pre-pregnancy obesity increase the risk of peripartum cardiomyopathy in women with live births?
Cohort (n=2,548,380)
Yes
Does pre-pregnancy obesity increase the risk of peripartum cardiomyopathy in women with live births?
Odds Ratio: 1.38 (95% CI 1.04–1.84)
Pre-pregnancy obesity is associated with an increased risk of peripartum cardiomyopathy, highlighting the importance of weight management before pregnancy.
May inform pre-pregnancy obesity counseling; leaves open causality and need for prospective validation in peripartum cardiomyopathy.
Objective The aim of this study is to evaluate the contribution of pre-pregnancy obesity and overweight to peripartum cardiomyopathy. Study Design This population-based study used linked birth record and maternal hospital discharge data from live births in California during 2007 to 2012 (n = 2,548,380). All women who had a diagnosis of peripartum cardiomyopathy during the childbirth hospitalization or who were diagnosed with peripartum cardiomyopathy during a postpartum hospital readmission within 5 months of birth were identified as cases. Pre-pregnancy body mass index (BMI, kg/m2) was classified as normal weight (18.5–24.9), overweight (25.0–29.9), obesity class 1 (30.0–34.9), obesity class 2 (35.0–39.9), and obesity class 3 (≥40). Because of small numbers, we excluded women with underweight BMI, and in some analyses, we combined obesity classes into one group. Logistic regression was used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) expressing associations between BMI and peripartum cardiomyopathy, adjusted for maternal age, race/ethnicity, education, health care payer, parity, plurality, and comorbidities. Results The overall prevalence of peripartum cardiomyopathy during hospital admissions was 1.3 per 10,000 live births (n = 320). Unadjusted ORs were 1.32 (95% CI: 1.01–1.74) for women with overweight BMI and 2.03 (95% CI: 1.57–2.62) for women with obesity, compared with women with normal pre-pregnancy BMI. Adjusted ORs were 1.26 (95% CI: 0.95–1.66) for overweight women and 1.38 (95% CI: 1.04–1.84) for women with obesity. The ORs suggested a dose–response relationship with increasing levels of obesity, but the 95% CIs for the specific classes of obesity included 1.00. Conclusion Pre-pregnancy obesity was associated with an increased risk of peripartum cardiomyopathy. These findings underscore the importance of BMI during pregnancy. There is a need to recognize the increased risk of peripartum cardiomyopathy in women with high BMI, especially in the late postpartum period.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2020) conducted a cohort in Peripartum cardiomyopathy (n=2,548,380). Pre-pregnancy obesity vs. Normal pre-pregnancy BMI (18.5-24.9 kg/m2) was evaluated on Diagnosis of peripartum cardiomyopathy during childbirth hospitalization or a postpartum hospital readmission within 5 months of birth (OR 1.38, 95% CI 1.04-1.84). Pre-pregnancy obesity was associated with a 38% increased odds of developing peripartum cardiomyopathy compared with normal pre-pregnancy body mass index (OR 1.38).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: